Jose Gomez‐Arroyo

3.1k citations

45 papers · 2.0k indexed · h-index 24

Pulmonary and Respiratory Medicine top 1%
Cardiology and Cardiovascular Medicine top 2%
Molecular Biology
Surgery top 10%
Cancer Research top 10%

Co-authors: Norbert F. Voelkel Harm Jan Bogaard Donatas Kraskauskas Shiro Mizuno László Farkas Antonio Abbate Aysar Alhussaini Daniela Farkas
Topics: Pulmonary Hypertension Research and Treatments (33 papers)Cardiovascular Function and Risk Factors (8 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers)
Cited by: Pulmonary and Respiratory Medicine Cardiology and Cardiovascular Medicine Cancer Research
Journals: Circulation PLoS ONE Circulation Research
Partner nations: United States Netherlands Japan

In The Last Decade

Jose Gomez‐Arroyo

44 papers receiving 2.0k citations

Peers

Countries citing papers authored by Jose Gomez‐Arroyo

Since Specialization

Citations

This map shows the geographic impact of Jose Gomez‐Arroyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jose Gomez‐Arroyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jose Gomez‐Arroyo more than expected).

Fields of papers citing papers by Jose Gomez‐Arroyo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jose Gomez‐Arroyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jose Gomez‐Arroyo. The network helps show where Jose Gomez‐Arroyo may publish in the future.

Co-authorship network of co-authors of Jose Gomez‐Arroyo

This figure shows the co-authorship network connecting the top 25 collaborators of Jose Gomez‐Arroyo. A scholar is included among the top collaborators of Jose Gomez‐Arroyo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jose Gomez‐Arroyo. Jose Gomez‐Arroyo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4 2024 ·EMBO Molecular Medicine ·(unknown),(unknown),Guolun Wang,Ying‐Wei Lan,Zicheng Deng,(unknown),(unknown),(unknown),Jose Gomez‐Arroyo,(unknown),(unknown),Jermaine Goveia,Peter Carmeliet,Vladimir V. Kalinichenko,Tanya V. Kalin	7
2	Hypoxia represses FOXF1 in lung endothelial cells through HIF-1α 2024 ·Frontiers in Physiology ·(unknown),(unknown),Jose Gomez‐Arroyo,(unknown),Vladimir V. Kalinichenko,Tanya V. Kalin	1
3	Demonstration of Safety in Wild Type Mice of npFOXF1, a Novel Nanoparticle-Based Gene Therapy for Alveolar Capillary Dysplasia with Misaligned Pulmonary Veins 2023 ·Biologics ·(unknown),Zicheng Deng,Yufang Zhang,(unknown),(unknown),(unknown),Samriddhi Shukla,Vladimir Ustiyan,Jose Gomez‐Arroyo,(unknown),Donglu Shi,Vladimir V. Kalinichenko,(unknown)	2
4	Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1 2023 ·Frontiers in Oncology ·(unknown),Zicheng Deng,(unknown),Samriddhi Shukla,Jose Gomez‐Arroyo,Donglu Shi,Vladimir V. Kalinichenko,Tanya V. Kalin	7
5	Distinct Platelet Ribonucleic Acid Signatures in Patients with Pulmonary Hypertension 2022 ·Annals of the American Thoracic Society ·(unknown),(unknown),Sjors G. J. G. In ‘t Veld,Anna E. Huis in ‘t Veld,Nik Sol,(unknown),(unknown),(unknown),(unknown),Jip Ramaker,(unknown),Edward P. Post,Esther J. Nossent,Anco Boonstra,Frances S. de Man,Anton Vonk Noordegraaf,Jose Gomez‐Arroyo,Myron G. Best,Tom Würdinger,Harm Jan Bogaard	2
6	Angiotensin converting enzyme 2 and angiotensin (1–7) axis in pulmonary arterial hypertension 2020 ·European Respiratory Journal ·Julio Sandoval,Leonardo del Valle‐Mondragón,Felipe Massó,(unknown),Tomás Pulido,Ricardo Teijeiro,Héctor González‐Pacheco,(unknown),(unknown),Araceli Páez,Gustavo Pastelín-Hernández,Jose Gomez‐Arroyo,Norbert F. Voelkel	31
7	Derivation and validation of a simple inflammation-based risk score system for predicting in-hospital mortality in acute coronary syndrome patients 2018 ·Journal of Cardiology ·Héctor González‐Pacheco,Rafael Bojalil,Luís M. Amezcua‐Guerra,Julio Sandoval,Guering Eid‐Lidt,Alexandra Arias‐Mendoza,(unknown),(unknown),Alfredo Altamirano‐Castillo,(unknown),(unknown),Armando Vázquez-Rangel,Antonio Abbate,Jose Gomez‐Arroyo,Carlos Martínez‐Sánchez	19
8	p53 Signaling Pathway Polymorphisms Associated With Emphysematous Changes in Patients With COPD 2017 ·CHEST Journal ·Shiro Mizuno,Takeshi Ishizaki,Maiko Kadowaki,(unknown),(unknown),(unknown),(unknown),Ken Nakagawa,Kazuhiro Osanai,Hirohisa Toga,Jose Gomez‐Arroyo,Donatas Kraskauskas,Carlyne D. Cool,Harm Jan Bogaard,Norbert F. Voelkel	26
9	The Need to Recognize the Pulmonary Circulation and the Right Ventricle as an Integrated Functional Unit: Facts and Hypotheses (2013 Grover Conference series) 2015 ·Pulmonary Circulation ·Norbert F. Voelkel,Harm Jan Bogaard,Jose Gomez‐Arroyo	22
10	Interventional and surgical therapeutic strategies for pulmonary arterial hypertension: Beyond palliative treatments 2015 ·Journal of Cardiology ·Julio Sandoval,Jose Gomez‐Arroyo,Jorge Gaspar,Tomás Pulido	22
11	The Role of Vascular Endothelial Growth Factor in Pulmonary Arterial Hypertension. The Angiogenesis Paradox 2014 ·American Journal of Respiratory Cell and Molecular Biology ·Norbert F. Voelkel,Jose Gomez‐Arroyo	135
12	Treatment for Pulmonary Arterial Hypertension–Associated Right Ventricular Dysfunction 2014 ·Annals of the American Thoracic Society ·Jose Gomez‐Arroyo,Julio Sandoval,Marc A. Simon,(unknown),Norbert F. Voelkel,Harm Jan Bogaard	26
13	Histone Deacetylase Inhibition with Trichostatin a does not Reverse Severe Angioproliferative Pulmonary Hypertension in Rats (2013 Grover Conference Series) 2014 ·Pulmonary Circulation ·Michiel Alexander de Raaf,(unknown),Jose Gomez‐Arroyo,(unknown),Daniela Farkas,Chris Happé,Norbert F. Voelkel,Harm Jan Bogaard	28
14	Severe Pulmonary Arterial Hypertension Induced by SU5416 and Ovalbumin Immunization 2012 ·American Journal of Respiratory Cell and Molecular Biology ·Shiro Mizuno,László Farkas,(unknown),Daniela Farkas,Jose Gomez‐Arroyo,Donatas Kraskauskas,Mark R. Nicolls,Carlyne D. Cool,Harm Jan Bogaard,Norbert F. Voelkel	72
15	Antioxidants for the Treatment of Patients with Severe Angioproliferative Pulmonary Hypertension? 2012 ·Antioxidants and Redox Signaling ·Norbert F. Voelkel,Harm Jan Bogaard,(unknown),László Farkas,Jose Gomez‐Arroyo,Ramesh Natarajan	33
16	Pathobiology of pulmonary arterial hypertension and right ventricular failure 2012 ·European Respiratory Journal ·Norbert F. Voelkel,Jose Gomez‐Arroyo,Antonio Abbate,Harm Jan Bogaard,Mark R. Nicolls	197
17	MicroRNA-199a-5p Is Associated With Hypoxia-Inducible Factor-1α Expression in Lungs From Patients With COPD 2012 ·CHEST Journal ·Shiro Mizuno,Harm Jan Bogaard,Jose Gomez‐Arroyo,Aysar Alhussaini,Donatas Kraskauskas,Carlyne D. Cool,Norbert F. Voelkel	83
18	A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects 2012 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Jose Gomez‐Arroyo,Sheinei Saleem,Shiro Mizuno,Aamer Syed,Harm Jan Bogaard,Antonio Abbate,Laimute Taraseviciene‐Stewart,Yon K. Sung,Donatas Kraskauskas,Daniela Farkas,Daniel H. Conrad,Mark R. Nicolls,Norbert F. Voelkel	150
19	Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats 2012 ·European Respiratory Journal ·(unknown),Gianluca Bagnato,László Farkas,Jose Gomez‐Arroyo,Daniela Farkas,Shiro Mizuno,Donatas Kraskauskas,Antonio Abbate,(unknown),N. F. Voelkel,Harm Jan Bogaard	46
20	The Role of Uric Acid in Pediatric Idiopathic Pulmonary Arterial Hypertension: Analysis From a 10-Year Registry 2010 ·CHEST Journal ·Jose Gomez‐Arroyo,Juan Pablo Sandoval,(unknown),(unknown),(unknown),Alfonso Buendía-Hernández,Juan Calderón‐Colmenero,Julio Sandoval,(unknown)	1

About Jose Gomez‐Arroyo

Jose Gomez‐Arroyo is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 45 papers that have together received 2.0k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (33 papers), Cardiovascular Function and Risk Factors (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.6k citations), Cardiology and Cardiovascular Medicine (820 citations) and Cancer Research (274 citations). Jose Gomez‐Arroyo has collaborated with scholars based in United States, Netherlands and Japan. Frequent co-authors include Norbert F. Voelkel, Harm Jan Bogaard, Donatas Kraskauskas, Shiro Mizuno, László Farkas, Antonio Abbate, Aysar Alhussaini, Daniela Farkas, Mark R. Nicolls and Jennifer I. Drake. Their work appears in journals such as Circulation, PLoS ONE and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact